<DOC>
	<DOCNO>NCT01161797</DOCNO>
	<brief_summary>The aim study evaluate correlation 1,5-Anhydroglucitol patient HbA1C &lt; 7 % , glycemic excursion assess continuous glucose monitoring system compare fructosamine .</brief_summary>
	<brief_title>1,5-AG Marker Postprandial Hyperglycemia Glucose Variability Well-controlled Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>1,5-Anhydroglucitol ( AG ) glucose analogue present plasma healthy subject . Physiologically , plasma level 1,5-AG stable small quantity excrete urine . It competitively reabsorb glucose renal tubule . Therefore , hyperglycemic state glycosuria present , glucose competitively inhibits renal tubular reabsorption 1,5-AG consequently plasma 1,5-AG level decrease . When glycemia normalize glycosuria resolve , 1,5-AG level increase . The usefulness 1 , 5-AG reflect glycemic excursion demonstrate moderately controlled patient extent , although study reveal controversial result . Therefore , aim study evaluate association 1,5-AG postprandial hyperglycemia determine use Continuous Glucose Monitoring System ( CGMS ) DM patient HbA1C &lt; 7 % evaluate usefulness 1,5-AG marker glycemic control compare HbA1C fructosamine .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>HbA1C &lt; 7 % HbA1c modification &lt; 0.5 % previous 3 month recent addition oral hypoglycemic medication change insulin dose &gt; 10 % previous 3 month pregnancy anemia ( Hb &lt; 10.0 g/dL ) liver disease ( ALT &gt; 2 UNL ) hypoalbuminemia ( albumin &lt; 3.5 g/dL ) serum creatinine &gt; 2 mg/dL acute chronic renal tubulointerstitial disease severe medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>1,5-Anhydroglucitol</keyword>
</DOC>